PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAglatimagene besadenovec
Aglatimagene besadenovec
Aglatimagene besadenovec is a gene pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
7426 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Prostatic neoplasmsD011471C61224021431108
Castration-resistant prostatic neoplasmsD0641292741619
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Neoplasm metastasisD009362EFO_00097083126
RecurrenceD012008123
GynecomastiaD006177N62112
HypersensitivityD006967EFO_0003785T78.4011
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Breast neoplasmsD001943EFO_0003869C50557
AdenocarcinomaD000230156
NeoplasmsD009369C802226
Ovarian neoplasmsD010051EFO_0003893C563315
Pancreatic neoplasmsD010190EFO_0003860C25334
CarcinomaD002277C80.01113
Non-small-cell lung carcinomaD002289313
Colorectal neoplasmsD015179212
Uterine cervical neoplasmsD002583222
Endometrial neoplasmsD016889EFO_0004230111
Show 15 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223C85.911
Triple negative breast neoplasmsD06472611
Lung neoplasmsD008175C34.9011
PharmacokineticsD01059911
Healthy volunteers/patients11
Pharmacological phenomenaD00006943711
Indications Without Phase
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameAglatimagene besadenovec
INNaglatimagene besadenovec
Description
Aglatimagene besadenovec is a gene pharmaceutical. It is currently being investigated in clinical studies.
Classification
Gene
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL3544993
ChEBI ID
PubChem CID
DrugBank
UNII ID5Z72SSS34W (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,116 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
13 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use